Skip to main content

EDITORIAL article

Front. Med.
Sec. Infectious Diseases: Pathogenesis and Therapy
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1478343
This article is part of the Research Topic Vaccine Clinical Development in Latin America: Achievements, Challenges, and Future Perspectives View all 5 articles

Editorial: Vaccine Clinical Development in Latin America: Achievements, Challenges, and Future Perspectives

Provisionally accepted
Rodrigo DeAntonio Rodrigo DeAntonio 1*Rolando Ulloa-Gutierrez Rolando Ulloa-Gutierrez 2,3
  • 1 CEVAXIN Centro de Vacunación e Investigación, Panama, Panama
  • 2 Dr. Carlos Sáenz Herrera National Children's Hospital, San José, San Jose, Costa Rica
  • 3 Academia Nacional de Medicina de Costa Rica (ACAMED), San Jose, Costa Rica

The final, formatted version of the article will be published soon.

    Keywords: Vaccination, Latin America, Children, Clinical development, Risk factors, Vaccine

    Received: 09 Aug 2024; Accepted: 26 Aug 2024.

    Copyright: © 2024 DeAntonio and Ulloa-Gutierrez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Rodrigo DeAntonio, CEVAXIN Centro de Vacunación e Investigación, Panama, Panama

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.